Grant-funding application assessment
Weighted technical and commercial assessment for a prominent U.S. Academic Medical Center in cell and gene therapy; the previous external assessment had taken four weeks.
For translation and technology-transfer teams
Move your promising research towards clearer funding, licensing, partnering and commercialisation decisions.
Bring your research evidence, funding criteria, intellectual property, translational readiness and market context into a more coherent path beyond the next award or decision.
Solutions shaped around your work
Choose the decision or workflow closest to the challenge you are working through.
Explore 6 practical blueprints designed around the decisions, evidence and workflows your organisation needs to move forward.
BD & Partnering Strategy
Business Development & Partnering Solutions for Academic Medical Centers
Technology Licensing & Out-LicensingTechnology Licensing and Out-Licensing Solutions for Academic Medical Centers
Tech Transfer & CommercializationTech Transfer and Commercialization Solutions for Academic Medical and Translational Centers
Search and Generative Engine OptimizationSearch and Generative Engine Optimization (S/GEO) for Academic Medical & Translational Centers
AI & Digital ArchitectureDigital Architecture for Translational Research and Technology Transfer
Partner & Investor PortalsPartner Portal Development for Academic Medical & Translational Centers
Critical Decision Analysis
Bring your decision into sharper focus.
We help you assess technical funding applications, compare opportunities, and connect scientific promise with the evidence, partner logic and operating steps required for commercialisation.
- 01
Which programme best meets the funding criteria and offers credible value beyond the grant period?
- 02
What evidence, validation gaps and commercial assumptions should influence your weighted ranking?
- 03
Which licensing, collaboration or spin-out route best fits your technology and institutional objective?
- 04
What do your prospective partners need to understand, and which information must remain controlled?
Evidence relevant to your work
See the delivery evidence, published thinking and proposed systems relevant to your challenge.
We distinguish completed delivery from thought leadership and proposal-stage architecture, so you can judge each example in the right context.
CRISPR preclinical-to-clinical decision tree
Published thought leadership comparing IND/CTA pathways across five major regulators and mapping CRISPR specificity, long-term safety, and in-vivo versus ex-vivo risks into a practical decision framework.
Proposed technical-dossier agent architecture
Proposal-stage estimate for reducing SME authoring effort by coordinating technical, quality-control, and reference agents, leaving approximately 20 hours for source validation and verification.
Choose the support you need
Move from a difficult decision to a system your team can use.
Start with one focused capability or combine all three around your decision, information and workflow requirements.
Decide
Strategic Consulting
Frame your funding, translational, licensing, partner and commercialisation choices around the available evidence.
Explore capability EngineerActiveArchitecture™
Design your opportunity, IP, review and partner workflows across institutional boundaries.
Explore capability ActivateVantagePoint™
Bring the translational, market and pipeline signals relevant to your team into a useful prioritisation view.
Explore capabilityA focused next conversation
Bring us the funding, research or commercialisation decision that needs a clearer route.
Start with your assessment criteria, evidence set, partner-fit or licensing question, and we will help you define the next step.